USV Private Executive and Leadership Team

Jogendra Sethi, the Chief Financial Officer at USV Private, directs all fiscal planning and capital allocation strategies. Overseeing the financial health of the organization, the Chief Financial Officer ensures rigorous compliance with international accounting standards while supporting the expansion of pharmaceutical manufacturing capabilities. This leadership role involves managing complex investment portfolios and optimizing cost structures to drive sustainable growth across global markets. By implementing robust financial controls, Jogendra Sethi directly impacts the long-term stability of the company. Ultimately, Sethi secures the necessary resources to fund research and development initiatives, ensuring the firm remains competitive within the biotechnology sector. Through precise fiscal oversight, the Chief Financial Officer maintains the balance between operational efficiency and aggressive market expansion, providing the necessary foundation for the company to achieve its ambitious long-term objectives in the pharmaceutical industry.

Jayant Dwivedy, the Executive Director & Chief Operating Officer at USV Private, manages the end-to-end manufacturing operations and supply chain logistics. Overseeing the production facilities, the Executive Director & Chief Operating Officer ensures that all pharmaceutical outputs meet stringent quality benchmarks and regulatory requirements. This leadership role involves streamlining internal processes to enhance productivity and reduce time-to-market for critical biotechnology products. By coordinating cross-functional teams, Jayant Dwivedy directly impacts the operational excellence of the firm. Ultimately, Dwivedy drives the scaling of manufacturing capacity to meet rising demand across diverse geographic regions. Through constant monitoring of production metrics, the Executive Director & Chief Operating Officer maintains high standards of operational efficiency, ensuring that the company delivers life-saving medications to patients worldwide while optimizing resource utilization and maintaining a lean, responsive manufacturing infrastructure.

Anuj Maheshwari, the President at USV Private, drives the overarching corporate strategy and market expansion initiatives. Overseeing the executive leadership team, the President ensures alignment between business units and the long-term vision of the organization. This leadership role involves identifying new market opportunities and fostering strategic partnerships that enhance the company's footprint in the pharmaceutical sector. By guiding the firm through complex regulatory landscapes, Anuj Maheshwari directly impacts the competitive positioning of the business. Ultimately, Maheshwari secures the company's status as a leader in biotechnology by championing innovation and operational excellence. Through decisive leadership, the President maintains a clear focus on delivering value to stakeholders while expanding the reach of the company's product portfolio across international markets, ensuring that the organization remains at the forefront of medical advancement and pharmaceutical manufacturing.

Esmail Samiwala, the President, Biologics at USV Private, directs the research, development, and commercialization of advanced biological therapies. Overseeing the specialized biologics division, the President, Biologics ensures that the company remains at the cutting edge of biotechnology innovation. This leadership role involves managing complex clinical trials and navigating the regulatory pathways required for bringing novel biological products to market. By integrating scientific research with commercial strategy, Esmail Samiwala directly impacts the growth of the biologics portfolio. Ultimately, Samiwala secures the company's future by expanding the pipeline of high-value therapeutic solutions. Through technical expertise and strategic vision, the President, Biologics maintains a focus on addressing unmet medical needs, ensuring that the organization continues to deliver sophisticated treatments that improve patient outcomes while maintaining a strong competitive position in the global biotechnology landscape.

Aparna Vishwasrao, the Chief Human Resources Officer at USV Private, architects the talent acquisition and organizational development strategies. Overseeing the workforce culture, the Chief Human Resources Officer ensures that the company attracts and retains top-tier scientific and operational talent necessary for pharmaceutical innovation. This leadership role involves designing comprehensive training programs and performance management systems that align individual contributions with corporate goals. By fostering an inclusive and high-performance environment, Aparna Vishwasrao directly impacts the overall engagement and productivity of the workforce. Ultimately, Vishwasrao secures the human capital required to sustain long-term growth and innovation in the biotechnology space. Through strategic workforce planning, the Chief Human Resources Officer maintains a competitive edge in the labor market, ensuring that the organization possesses the expertise and leadership depth to navigate the complexities of the global pharmaceutical industry.